ATE552269T1 - Zykliertes, nichtnatives synthetisches peptid und peptidkomplex mit besagtem zykliertem peptid zur veranlassung und charakterisierung der vorbeugung oder behandlung von störungen bei säugetieren - Google Patents

Zykliertes, nichtnatives synthetisches peptid und peptidkomplex mit besagtem zykliertem peptid zur veranlassung und charakterisierung der vorbeugung oder behandlung von störungen bei säugetieren

Info

Publication number
ATE552269T1
ATE552269T1 AT09766020T AT09766020T ATE552269T1 AT E552269 T1 ATE552269 T1 AT E552269T1 AT 09766020 T AT09766020 T AT 09766020T AT 09766020 T AT09766020 T AT 09766020T AT E552269 T1 ATE552269 T1 AT E552269T1
Authority
AT
Austria
Prior art keywords
peptide
cycled
mammals
prevention
treatment
Prior art date
Application number
AT09766020T
Other languages
English (en)
Inventor
Serge Vicens
Gregory Hottin
Original Assignee
Papierok Gerard
Vincens Serge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Papierok Gerard, Vincens Serge filed Critical Papierok Gerard
Application granted granted Critical
Publication of ATE552269T1 publication Critical patent/ATE552269T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT09766020T 2008-06-19 2009-06-18 Zykliertes, nichtnatives synthetisches peptid und peptidkomplex mit besagtem zykliertem peptid zur veranlassung und charakterisierung der vorbeugung oder behandlung von störungen bei säugetieren ATE552269T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0803436A FR2932802B1 (fr) 2008-06-19 2008-06-19 Peptide de synthese non natif cyclise et complexe de peptides comprenant ledit peptide cyclise, destine a induire et a caracteriser la prevention ou le traitement d'affections chez les mammiferes
PCT/FR2009/000730 WO2009153458A2 (fr) 2008-06-19 2009-06-18 Peptide de synthese non natif cyclise et complexe de peptides comprenant ledit peptide cyclise, destine a induire et a caracteriser la prevention ou le traitement d'affections chez les mammiferes

Publications (1)

Publication Number Publication Date
ATE552269T1 true ATE552269T1 (de) 2012-04-15

Family

ID=40352162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09766020T ATE552269T1 (de) 2008-06-19 2009-06-18 Zykliertes, nichtnatives synthetisches peptid und peptidkomplex mit besagtem zykliertem peptid zur veranlassung und charakterisierung der vorbeugung oder behandlung von störungen bei säugetieren

Country Status (7)

Country Link
US (1) US20110104064A1 (de)
EP (1) EP2288619B8 (de)
AT (1) ATE552269T1 (de)
ES (1) ES2385436T3 (de)
FR (1) FR2932802B1 (de)
PT (1) PT2288619E (de)
WO (1) WO2009153458A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3000402A1 (fr) * 2012-12-28 2014-07-04 Vibrac Composes peptidiques mono-ou multi-epitopiques destines a la prevention et au traitement des leishmanioses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2829767B1 (fr) * 2001-09-14 2004-02-27 Gerard Papierok Composes peptidiques destines a la prevention et au traitement d'affections chez les mammiferes
FR2863272B1 (fr) * 2003-11-19 2006-06-09 Inst Rech Developpement Ird Nouveaux moyens pour la prevention des leishmanioses
WO2006058243A2 (en) * 2004-11-24 2006-06-01 Yale University Leishmania antigens and related compositions and uses

Also Published As

Publication number Publication date
EP2288619B1 (de) 2012-04-04
PT2288619E (pt) 2012-06-27
FR2932802A1 (fr) 2009-12-25
US20110104064A1 (en) 2011-05-05
WO2009153458A2 (fr) 2009-12-23
EP2288619A2 (de) 2011-03-02
WO2009153458A3 (fr) 2010-03-18
WO2009153458A9 (fr) 2011-06-23
FR2932802B1 (fr) 2010-08-20
EP2288619B8 (de) 2012-08-01
ES2385436T3 (es) 2012-07-24

Similar Documents

Publication Publication Date Title
EP4446337A3 (de) Mutiertes glycoprotein des vesikulären stomatitisvirus
NZ603016A (en) Novel immunotherapy against several tumors including neuronal and brain tumors
EP4349360A3 (de) Peptid mit faltenverbessernder wirkung und verwendungen davon
PE20120358A1 (es) Mutantes fgf21 y usos de los mismos
SI2071028T1 (sl) Antigen peptid pridobljen iz WT ki veže HLA DR
JP2014518542A5 (de)
IN2014CN04498A (de)
ATE417595T1 (de) Keratin-bindende polypeptide
EP3936141A3 (de) Antiseneszenzverbindungen und verwendungen davon
NZ711037A (en) Peptides and compositions for treatment of joint damage
ATE536880T1 (de) Impfstoff beinhaltend amb a 1 peptide zur behandlung von traubenkraut-allergie
NZ599604A (en) Synthetic myostatin peptide antagonists
MX385794B (es) Péptidos inhibidores obtenidos del receptor desencadenante expresado en células mieloides de tipo 1 (trem-1) y transcrito similar a trem 1 (tlt-1) y usos de los mismos.
EP4567043A3 (de) Verbindungen zur induktion von geweberegeneration und verwendungen davon
MX2021014497A (es) Peptidos.
WO2012174397A3 (en) Anti-inflammatory pharmaceutical products
NZ609474A (en) Fviii peptides for immune tolerance induction and immunodiagnostics
SG10201901656WA (en) Nutritional compositions containing a peptide component with adiponectin stimulating properties and uses thereof
ATE493999T1 (de) Nahrungsmittel enthaltend dipeptide mit blutdrucksenkenden eigenschaften.
ATE552269T1 (de) Zykliertes, nichtnatives synthetisches peptid und peptidkomplex mit besagtem zykliertem peptid zur veranlassung und charakterisierung der vorbeugung oder behandlung von störungen bei säugetieren
NZ707615A (en) Novel immunotherapeutic molecules and uses thereof
BR112014001844A2 (pt) gene induzindo o alongamento de raízes ou aumentando a biomassa, e uso do mesmo
ATE378351T1 (de) Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren
NZ706202A (en) Peptide antagonists of the vasopressin-2 receptor
ATE552271T1 (de) Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon